Exit Planning for Home Health Owners: A 2026 Playbook
On July 6, 2026, CMS published the CY2027 Home Health Prospective Payment System proposed rule in the Federal Register, with public comment open through August 31, 2026. On paper it reads as a net positive: an aggregate update of about 2.4%. Underneath, the number is thinner than it looks. The payment update is 2.1% (a 3.1% market basket reduced by a full 1.0 percentage point for productivity), and CMS is again applying a temporary adjustment to recoup part of the outstanding PDGM balance. For most owners, real margin does not move up. It gets squeezed. If you run a Medicare-certified home health agency, that is the backdrop against which the value of your life’s work is now being set.Exit planning for home health owners is the multi-year process of preparing your agency, your financials, and yourself so that when you decide to sell, the business is already worth more and easier for a buyer to underwrite. It is not the same as deciding to sell today. It is the work you do in the 12 to 36 months beforehand so that the decision, when it comes, is made from strength instead of fatigue. As of August 2026, with reimbursement pressure rising and buyer demand still healthy, that preparation window is where the money is won or lost.
This guide walks through what exit planning actually involves, how the CY2027 changes affect your timeline, what buyers reward and penalize, who is acquiring agencies in 2026, and how to decide whether to move now or wait. The numbers here are ranges, not promises. Every multiple depends on your payer mix, geography, staff retention, compliance history, and referral durability.
What is exit planning for a home health agency?
Exit planning is the deliberate, staged preparation of a home health agency for an eventual ownership change, focused on raising value and reducing buyer risk before a sale process ever begins. Think of value as being set by two sets of forces. One set sits outside your control: Medicare reimbursement, Medicare Advantage authorization pressure, wage inflation, and the CMS rule cycle. The other set sits entirely inside your control: the cleanliness of your books, how dependent the business is on you personally, staff retention, compliance readiness, and the concentration of your referral sources.
Exit planning is the practice of spending the months before a sale converting the second set into a higher, more defensible number. Owners who do this arrive at the negotiating table with proof. Owners who skip it arrive with a story, and buyers do not pay for stories. As of August 2026, the gap between a prepared agency and an unprepared one of similar size is often measured in whole turns of EBITDA.
How do the CY2027 Medicare changes affect your exit?
The CY2027 proposed rule matters to your exit because it signals continued reimbursement pressure, and buyers price agencies on where cash flow is heading, not just where it has been. The headline update is a net increase of roughly 2.4% for CY2027, but it is built from a 2.1% payment update (a 3.1% market basket minus a 1.0 percentage point productivity cut) plus a small outlier adjustment, and CMS is layering in a temporary adjustment to recoup 10% of the outstanding PDGM balance from prior years. In plain terms, the top line ticks up while structural clawbacks and a productivity haircut keep real per-visit economics tight. Comments on CMS-1844-P are open through August 31, 2026.
For an owner, the practical effect is twofold. First, thin and uncertain reimbursement makes operational quality (star ratings, low turnover, diversified payers) worth more, because it is what protects margin when rates do not cooperate. Second, it rewards owners who plan ahead of the rule cycle rather than reacting after each January. A buyer reviewing your agency in 2026 is asking a simple question: when the next rule lands, does this business hold its margin or does it wobble. Exit planning is how you make the answer obvious before they ask.
How far in advance should you start exit planning?
Most owners should begin exit planning 12 to 36 months before they intend to close a sale, and the earlier end of that range produces the stronger result. The reason is mechanical. Buyers typically look at a trailing 12-month period, and often a two to three year trend, to judge earnings quality. Improvements you make take time to show up in the numbers a buyer actually reviews. If you clean up owner add-backs, cut caregiver turnover, and diversify referral sources this quarter, those gains need several reporting periods to become credible history rather than a promise.
In our experience at Vallexa Advisors, most owners come to us six to nine months later than they should. There is usually still time to fix the highest-impact items, but a longer runway lets you address structural issues (owner dependency, payer concentration, a soft compliance record) that cannot be repaired in a single quarter. If retirement or a health event is forcing the timeline, planning still helps: even 90 days of focused preparation can protect value that would otherwise leak at the diligence stage.
What is the home health exit planning timeline, step by step?
The home health exit planning timeline moves from knowing your number to running a confidential process, with the value-building work concentrated in the middle. Here is the sequence we use with owners.
- Establish a baseline valuation. Get an honest read on what your agency is worth today, using real financials and current market multiples, so every later decision is measured against a number, not a hope.
- Clean up the financials. Separate personal expenses from the business, document legitimate add-backs, reconcile to tax returns, and produce a clear trailing 12-month view. Buyers pay for earnings they can trust.
- Reduce owner dependency. Build a management layer that runs intake, scheduling, billing, and referrals without you. An agency that needs the founder in every decision is worth less than one that does not.
- Stabilize staffing and retention. Track and improve caregiver and clinician turnover, because dependable hours are the asset a buyer is really acquiring. Document your recruiting and retention systems.
- Shore up compliance and star ratings. Close survey findings, tighten documentation, and protect your CMS star rating. Ratings act as a direct value multiplier and a failed survey can erase a turn of value overnight.
- Optimize payer mix. Understand your blend of Medicare, Medicare Advantage, Medicaid, and private pay, and reduce over-reliance on any single payer or referral source. Payer mix is the single largest driver of your multiple.
- Assemble your advisory team. Bring in an M&A advisor who knows home health, a healthcare transaction attorney, and a tax advisor, ideally well before you list, so the process runs on your terms.
- Run a confidential, competitive process. Take the prepared agency to a curated set of qualified buyers under NDA, create real competition, and negotiate from proof rather than pressure.
What makes a home health agency more valuable to buyers?
A home health agency is more valuable when its earnings are clean, its operations run without the owner, and its risk is spread across payers, referrers, and staff rather than concentrated in one place. Buyers reward durability and penalize dependency. The table below maps the drivers that lift a multiple against the eroders that pull it down. As of August 2026, Medicare-certified skilled home health typically commands 1.5x to 2.0x higher multiples than non-certified private duty, and scaled, diversified platforms trade several turns above tuck-in agencies, though every range depends on the specifics of your business.
| Value drivers (raise the multiple) | Value eroders (lower the multiple) |
|---|---|
| Clean, reconciled financials with documented add-backs | Commingled personal and business expenses |
| Management team that runs the agency without the owner | Owner personally holds the key referral relationships |
| Low, stable caregiver and clinician turnover | Chronic staffing gaps and unfilled referrals |
| Diversified payer mix and referral base | Heavy reliance on one payer or one referral source |
| Strong CMS star ratings and a clean survey history | Recent failed surveys or open billing audit issues |
| Multi-office or multi-state footprint (platform scale) | Single small office with limited census |
Who buys home health agencies in 2026, and what are they paying?
In 2026, home health agencies are bought by strategic operators, private-equity-backed platforms, regional consolidators, and individual buyers using SBA financing, and each type prices differently. Deal activity is holding: home health and hospice M&A reached 110 transactions in 2025, up from 97 in 2024, and private-equity activity in home-based care expanded 53.6% year over year in 2025. In Q2 2026, multiples firmed at the upper end, with larger hospice and platform add-ons in the $30M to $120M enterprise value range closing around 11x to 13x EBITDA, while smaller and tuck-in deals stayed disciplined. Your agency’s place in that spread depends on scale, payer mix, and preparation.
| Buyer type | What they want | Typical posture |
|---|---|---|
| Strategic operator | Adjacent geography, referral overlap, clinical fit | Pays for synergy and clean integration |
| PE-backed platform | Scale, EBITDA credibility, diversified payers | Pays up for platform-quality assets, disciplined on tuck-ins |
| Regional consolidator | Census, market share, staffing capacity | Competitive on well-run agencies in target states |
| Individual buyer (SBA) | Turnkey operation, transferable license, steady cash flow | Smaller deals, financing-dependent, values owner transition |
The takeaway is that there is no single “market price.” A prepared agency invites more buyer types into the room, and more buyers means real competition, which is where premiums come from. Structural demand supports this: the U.S. home care services market is projected near $659.5B by the end of 2026 and heading toward roughly $1.79T by 2036, an aging-population tailwind that keeps capital pointed at the sector.
Should you sell now or wait for the next rule cycle?
Whether to sell now or wait depends less on the calendar and more on how prepared your agency is and how much reimbursement risk you are comfortable carrying. If your books are clean, your team runs without you, and your payer mix is diversified, current buyer demand and firm upper-end multiples make a well-run 2026 process attractive. If those fundamentals are not in place yet, waiting can be the right call, but only if you use the time to build value rather than to postpone the decision.
The mistake to avoid is passive waiting. Reimbursement pressure is not going away, and each rule cycle adds uncertainty that buyers price in. The owners who do best are the ones who treat the next 12 to 24 months as a preparation window: know your number, fix the fixable, and be ready to move when demand and your readiness line up. That is a decision made from strength, and it is the entire point of exit planning.
Start with your number, then build the plan
You cannot plan an exit around a value you have not measured. Get a current, no-cost estimate of what your agency is worth, then talk it through with an advisor who works only in healthcare.
Estimate your agency’s value with the ValueMyBusiness calculator or start a confidential, no-obligation conversation with Vallexa Advisors.
Frequently asked questions about home health exit planning
How long does exit planning for a home health agency take?
Most owners plan for 12 to 36 months, because buyers judge earnings on a trailing 12-month and multi-year trend, so improvements need time to show up in the financials they review. Shorter timelines still help, but a longer runway lets you fix structural issues like owner dependency and payer concentration.
What is the 36-month Medicare rule, and does it block a sale?
The 36-month rule generally requires a Medicare-certified home health agency that changes majority ownership within 36 months of enrollment or its last change of ownership to re-enroll and undergo a new state survey and certification rather than transfer its existing billing privileges. It does not block a sale, but it changes the structure and timing, so both parties should confirm current CMS requirements with counsel before signing. Always verify the latest CMS guidance, because enrollment rules are updated periodically.
Can I plan an exit and still keep working after the sale?
Yes. Many owners negotiate a transition period, a consulting role, or a partial sale that keeps them involved while de-risking their personal balance sheet. Buyers often prefer a smooth owner transition, especially individual and SBA buyers, so continued involvement can be a value point rather than a complication.
Do I need audited financials to sell?
Audited statements are not always required, but clean, reconciled financials that tie to your tax returns are. For larger deals a buyer may request a quality-of-earnings review. Getting your books in order early is one of the highest-return steps in exit planning, because it protects value at the diligence stage where deals commonly lose price.
How is confidentiality protected during a sale?
A well-run process discloses your identity only to qualified buyers under a signed non-disclosure agreement, and shares detailed financials in stages. This protects your referral relationships, staff, and patients from disruption while you explore a sale. Confidentiality-first process design is a core reason owners work with an advisor rather than approaching buyers directly.
My margins are thin right now. Is it still worth planning an exit?
Yes, and thin margins are a reason to start sooner, not later. Exit planning is precisely the work that lifts margin and reduces risk before a buyer looks: cutting turnover, tightening compliance, and diversifying payers. Waiting without acting usually means facing the same margins plus another rule cycle of uncertainty.
What does it cost to work with an M&A advisor?
Vallexa Advisors works on 100% success-based fees, with no upfront charges, so our compensation is tied to closing a sale you are satisfied with. Fee structures vary across the industry, so confirm the arrangement in writing before you engage anyone, and make sure the advisor knows the home health space specifically.
About the author
Jason Atty is the founder of Vallexa Advisors, a healthcare-only M&A advisory firm focused on home health, hospice, and home care. Vallexa helps agency owners understand value, prepare intelligently, and run confidential, competitive sale processes that attract qualified buyers, on 100% success-based fees. The firm combines a nationwide buyer network with deep, vertical-specific transaction experience so owners make exit decisions from a position of knowledge. For related reading, see our guides on the steps to selling a healthcare agency and long-term exit strategy and succession planning.
Build your exit plan with a healthcare-only advisor
Whether you plan to sell next quarter or in three years, the preparation starts the same way. Talk with Vallexa Advisors about a staged plan built around your agency’s numbers, on 100% success-based fees.
Request a free confidential consultation · Value your agency now · Ask us for the pre-sale readiness checklist to score how buyer-ready your agency is today.
More resources for home health owners
- Vallexa home health M&A advisory
- When to sell a home health agency: reading the timing signals
- What buyers look for in a home health agency
- Home health agency valuation: what your agency is worth now
- Selling a home health agency to private equity
- Exits.ai: anonymous buyer mandates and demand
- Approved.Loans: SBA and buyer financing
Sources: CMS CY2027 Home Health Prospective Payment System Proposed Rule Fact Sheet (CMS-1844-P), cms.gov, 2026; Federal Register 91 FR 41216, July 6, 2026; MedPAC home health analysis, medpac.gov, 2026; Home Health Care News, 2026; independent 2026 home health and hospice M&A and EBITDA multiple reports. Figures are as of August 2026 and may change.
Educational only. Not legal, financial, or tax advice. Healthcare M&A outcomes depend on specific facts, payer mix, market conditions, and regulatory context. Speak with qualified counsel before acting on anything in this document.
Estimated reading time: 12 minutes
